… (MJFF) is soliciting feedback on a document that aims to provide researchers and the biopharmaceutical industry … in Parkinson's Disease is available for review and comment until September 15, 2019. There is a huge unmet need … for Parkinson's, particularly treatments that could prevent or slow overall disease progression. The goals of …

… doesn't help people if we don’t know how those changes lead to PD. We have used a computer program to identify genes that are turned on or off … genetic changes that put people at risk of PD target gene expression. To do this, we will use gene editing tools to …

… disease, 14-year-old Zoe Butchen knew she wanted to find a way to support her father and others living with … in any way she could. Being philanthropic-minded, Zoe combined three things that she loves — Taylor Swift, dancing … of ways that people can get involved.  The best way is to visit www.danceshakedonate.com and watch our videos to get …

… This past October, Austrian biotech AFFiRiS announced $1.5 million in … disease (PD), called PD01. Then, in November, the company announced 30 million Euros in additional funding … Alzheimer’s vaccines. In this podcast, Dave Iverson speaks with AFFiRiS’ Chief Medical Officer Achim Schneeberger …

… The Michael J. Fox Foundation (MJFF) has funded researchers to further investigate this connection: One such study is searching to find out if an increased expression of the protein alpha-synuclein might be the … in the past need to have very frequent dermatologic visits if they take levodopa, as the drug could cause their …

… University has accelerated a promising new PD treatment toward the clinic. Instead of targeting the dopamine system, … will hit a wall,” the paper wrote. In the modern era of complex disease, blue-chip drugmakers’ in-house research … can liken it to a dimmer switch on a light in your home, where you can turn up the gain of the receptor and its …